Platelet function analysis with point-of-care methods;Messung der thrombozytenfunktion mit point-of-care-methoden

Herz

Volumn 33, Issue 4, 2008, Pages 297-305

  Görlinger, Klaus ^a   Jambor, Csilla ^b   Dirkmann, Daniel ^a   Dusse, Fabian ^a   Hanke, Alexander ^a   Adamzik, Michael ^a   Hartmann, Matthias ^a   Philipp, Sebastian ^a   Weber, Artur Aron ^a   Rahe Meyer, Niels ^c  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cardiac surgery; Cardiology; Impedance aggregometry; Platelet function analysis; Thrombelastometry

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; FIBRINOGEN; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN;

ANALYZER; FIBRINOLYSIS; HUMAN; INTERMETHOD COMPARISON; POINT OF CARE TESTING; RELIABILITY; REVIEW; SENSITIVITY AND SPECIFICITY; THROMBOCYTE FUNCTION; VON WILLEBRAND DISEASE;

EID: 46449083575     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-008-3130-4     Document Type: Review

References (63)

1. Anderson L, Quasim I, Soutar R, et al. An audit of red cell and blood product use after the institution of thromoelastometry in a cardiac intensive care unit. Transfus Med 2006 16:31-9.
2. Brilakis ES, Banerjee S, Berger PB. Perioperative management of patients with coronary stents. J Am Coll Cardiol 2007;49:2145-50.
3. Calatzis A, Heesen M, Spannagl M. Patientennahe Sofortdiagnostik von Hämostasestörungen in der Anästhesie und Intensivmedizin. Anaesthesist 2003;52:229-37.
4. Calatzis A, Pape KW von, Reininger AJ, et al. Prevalence of aspirin non-response in out-patients and in-patients as determined by multiple electrode aggregometry. Blood 2006;108:abstract 879.
5. Calatzis A, Theisen F, Reininger AJ, et al. Monitoring of clopidogrel using multiple electrode aggregometry. Blood 2006;108:abstract 883.
6. Calatzis A, Witwer B, Krueger B. A new approach to platelet function analysis in whole blood - the Multiplate analyser. Platelets 2004;15:479-517.
7. Cammerer U, Dietrich W, Rampf T, et al. The predictive value of modified computerized thromboelastography and platelet function analysis for postoperative blood loss in routine cardiac surgery. Anesth Analg 2003;96:51-7.
8. Chakroun T, Gerotziafas G, Robert F, et al. In vitro aspirin resistance detected by PFA-100® closure time: pivotal role of plasma von Willebrand factor. Br J Haematol 2004;124:80-5.
9. Cho KH, Woo S, Hur CH, et al. Comparative study of heparinase treated activated clotting time with heparinase treated thrombelastography for detecting residual heparin effects following cardiopulmonary bypass. Korean J Anesthesiol 1995;29:850-7.
10. Eisenstein EL, Anstorm KJ, Kong DF, et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 2007;297:159-68.
11. Fattorutto M, Pradier O, Schmartz D, et al. Does the platelet function analyser (PFA-100) predict blood loss after cardiopulmonary bypass? Br J Anaesth, 2003;90:692-3.
12. Favaloro EJ, Facey D. Henniker A. Use of a novel patelet function analyzer (PFA-100) with high sensitivity to disturbances in von Willebrand factor to screen for von Willebrand's disease and other disorders. Am J Hematol 1999;62:165-74.
13. Franchini M, Zugni C, Veneri D, et al. High prevalence of acquired von Willebrand's syndrome in patients with thyroid diseases undergoing thyroid surgery. Haematologica 2004;89:1341-6.
14. Geiger J, Teichmann L, Grossmann R, et al. Monitoring of clopidogrel action: comparison of methods. Clin Chem 2005;51:957-65.
15. Görlinger K. ROTEM® - erweitertes perioperatives Gerinnungsmanagement. J Anästh Intensivbeh 2005;12:53-8.
16. Görlinger K. Gerinnungsmanagement bei Lebertransplantationen. Hämostaseologie 2006;26:Suppl 1:S64-75.
17. Görlinger K. Ist der Einsatz von Point-of-Care zur Gerinnungsdiagnostik effizient? Interdisziplinäre Intensivmedizin Aktuell, Bd 1. Nürnberg: MEPS - Medical Event & Publisher Services, 2008:249-66.
18. Görlinger K, Dirkmann D, Hanke AA, et al. Inpact of ROTEM® -based coagulation management on usage of blood components and cost saving in LTX. Anesthesiology 2007;107:abstract 2124.
19. Görlinger K, Herold U, Jakob H, et al. ROTEM-based coagulation management in acute type A aortic dissection: medical and economical aspects. J Anästh Intensivbeh 2007;14:89-90.
20. Görlinger K, Jambor C, Hanke A, et al. Thrombelastometry and impedance aggregometry based algorithm for coagulation management in cardiac surgery. Intensive Care Med 2007;33:Suppl 2:S196.
21. Görlinger K, Jambor C, Hanke AA, et al. Perioperative coagulation management and control of platelet transfusion by point-of-care platelet function analysis. Transfus Med Hemother 2007;34:396-411.
22. Grumann T, Diehl P, Bode C, et al. Ist die Stentthrombose die neue Achillesferse der interventionellen Kardiologie? Hämostaseologie 2007;27:344-50.
23. Gum PA, Kottke-Marchant K, Poggio ED, et al. Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol 2001;88:230-5.
24. Gum PA, Kottke-Marchant K, Welsh PA, et al. A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol 2003;41:961-5.
25. Hayward CP, Harrison P, Cattaneo M, et al. The Platelet Physiology Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis: Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function. J Thromb Haemost 2006;4:312-9.
26. Hertfelder HJ, Bös M, Weber D, et al. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting. Semin Thromb Hemost 2005;31:426-40.
27. Homoncik M, Gessl A, Ferlitsch A, et al. Altered platelet plug formation in hyperthyroidism and hypothyroidism. J Clin Endocrinol Metab 2007;92:3006-12.
28. Ivandic BT, Schlick P, Staritz P, et al. Determination of clopidogrel resistance by whole blood platelet aggregometry and inhibitors of the P2Y12 receptor. Clin Chem 2006;52:383-8.
29. Jambor C, Weber C, Gerhardt K, et al. Point of care measuring of platelet aggregation with the novel impedance aggregometer Multiplate - the optimal preanalytical conditions required. DAK 2007; Hamburg, 5.-8. Mai 2007:PO 4.6.8.
30. Kalb M, Scharbert G, Kress HG, et al. Monitoring of the reversing effect of desmopressin on cyclooxygenase-I-induced platelet inhibition. Anesthesiology 2005;103:abstract 394.
31. Karger R, Donner-Banzhoff N, Müller HH, et al. Diagnostic performance of the platelet function analyzer (PFA-100) for the detection of disorders of primary haemostasis in patients with a bleeding history - a systematic review and metaanalysis. Platelets 2007;18:249-60.
32. Karkouti K, Wijeysundera DN, Yau TM, et al. The independent association of massive blood loss with mortality in cardiac surgery. Transfusion 2004;44:1453-62.
33. Khan H, Belsher J, Yilmaz M, et al. Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients. Chest 2007;131:1308-14.
34. Korte W. Fibrinmonomer und Faktor XIII. Neues Konzept bei ungeklärter intraoperativer Blutungsneigung. Hämostaseologie 2006;26:Suppl 1:S30-5.
35. Koscielny J, Ziemer S, Radtke H, et al. Präoperative Identifikation von Patienten mit (primären) Hämostasestörungen. Ein praktisches Konzept. Hämostaseologie 2007;27:177-84.
36. Lang T, Depka M von. Diagnostische Möglichkeiten und Grenzen der Thrombelastometrie/-graphie. Hämostaseologie 2006;23:Suppl 1:S20-9.
37. Lasne D, Fiemeyer A, Chatellier G, et al. A study of platelet functions with a new analyzer using high shear stress (PFA 100) in patients undergoing coronary artery bypass graft. Thromb Haemost 2000;84:794-9.
38. Lee A, Chui PT, Aun CS, et al. Incidence and risk of adverse perioperative events among surgical patients taking traditional Chinese herbal medicines. Anesthesiology 2006;105:454-61.
39. Levy JH, Tanaka KA. The anticoagulated patient: strategies for effective blood loss management. Surgery 2007;142:Suppl:S71-7.
40. MacLennan S, Williamson LM. Risks of fresh frozen plasma and platelets. J Trauma 2006;60:Suppl:S46-50.
41. Mahmud E, Cavendish JJ, Tsimikas S, et al. Elevated plasma fibrinogen level predicts suboptimal response to therapy with both single- and double-bolus eptifibatide during percutaneous coronary intervention. J Am Coll Cardiol 2007;49:2163-71.
42. Mammen EF, Comp PC, Gosselin R, et al. PFA-100 system: a new method for assessment of platelet dysfunction. Semin Thromb Hemost 1998;24:195-202.
43. Mani H, Linnemann B, Luxembourg B, et al. Response to aspirin and clopidogrel monitored with different platelet function methods. Platelets 2006;17:303-10.
44. McCrath DJ, Cerboni E, Frumento RJ, et al. Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction. Anesth Analg 2005;100:1576-83.
45. Mittermayr M, Margreiter J, Velik-Salchner C, et al. Effects of protamine and heparin can be detected and easily differentiated by modified thrombelastography (ROTEM®): an in vitro study. Br J Anaesth 2005;95:310-6.
46. Mueller T, Dieplinger B, Poelz W, et al. Utility of whole blood impedance aggregometry for the assessment of clopidogrel action using the novel Multiplate® analyzer - comparison with two flow cytometric methods. Thromb Res 2007;4:249-58.
47. Niggemeier M. Diagnostik der Thrombozytenfunktion unter Zusatz der Glykoprotein-IIb/IIIa-Rezeptorantagonisten Tirofiban - Vergleich der "Point of Care" Verfahren Thrombelastographie, Impedanzaggregometrie und "Platelet Function Analyser" (PFA-100) bei verschiedenen Tirofibankonzentrationen. Dissertation, HHU Düsseldorf, 2004 (http://docserv.uni-duesseldorf.de/servlets/DocumentServl et?id=2944).
48. Pfanner G, Koscielny J, Pernerstorfer T, et al. Präoperative Blutungsanamnese. Empfehlungen der Arbeitsgruppe perioperative Gerinnung der Österreichischen Gesellschaft für Anästhesiologie, Reanimation und Intensivmedizin. Anästhesist 2007;56:604-11.
49. Poston R, Gu J, Manchio J, et al. Platelet function tests predict bleeding and thrombotic events after off-pump coronary bypass grafting. Eur J Cardiothorac Surg 2005;27:584-91.
50. Rahe-Meyer N, Gilde I, Calatzis A. Multiple electrode aggregometry is a predictive marker of transfusion requirements during open heart surgery. Hämostaseologie 2006;26:A78.abstract P352.
51. Reinhöfer M, Brauer M, Franke U, et al. The value of rotational thrombelastometry to monitor disturbed perioperative haemostasis and bleeding risk in patients with cardiopulmonary bypass. Blood Coagul Fibrinolysis 2008;19:212-9.
52. Roschitz B, Thaller S, Koestenberger M, et al. PFA-100 closure time in preoperative screening in 500 pediatric patients. Thromb Haemost 2007;98:243-7.
53. Rott H, Halimeh S, Kappert G, et al. Most unexpected bleeding complications during or after surgery in German patients occur due to acquired aspirin-related thrombocytopathia or von Willebrand's disease. 27th WFH World Congress of Hemophilia, Vancouver, May 21-25, 2006.
54. Sachs UJH, Bein G. Transfusionsassoziierte akute Lungeninsuffizienz (TRALI). Diagnose, Therapie und Prävention. Anästhesiol Intensivmed Notfallmed Schmerzther 2007;42:774-81.
55. Seyfert UT, Haubelt H, Vogt A, et al. Variables influencing Multiplate whole blood impedance platelet aggregometry and turbidimetric platelet aggregation in healthy individuals. Platelets 2007;18:199-206.
56. Shore-Lesserson L, Manspeizer HE, DePerio M, et al. Thromboelastography- guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 1999;88:312-9.
57. Spalding GJ, Hartrumpf M, Sierig T, et al. Cost reduction of perioperative coagulation management in cardiac surgery: value of "bedside" thrombelastography (ROTEM). Eur J Cardiothorac Surg 2007;31:1052-7.
58. Spiel AO, Mayr FB, Firbas C, et al. Validation of rotational thrombelastography in a model of systemic activation of fibrinolysis and coagulation in humans. J Thromb Haemost 2006;4:411-6.
59. Toth O, Calatzis A, Penz S, et al. Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood. Thromb Haemost 2006;96:781-8.
60. Vincentelli A, Susen S, Le Tourneau T, et al. Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med 2003;349:343-9.
61. Weber AA, Adamzik M, Bachmann HS, et al. Methoden zur Messung der Acetylsalizylsäure- bzw. Clopidogrelresistenz. Hämostaseologie 2008;28:66-71.
62. Wittmann G, Romann A, Conell B, et al. Functional quality control of platelet concentrates using multiple electrode aggregometry. 50th Annual Meeting of the Society of Thrombosis and Haemostasis Research, Basel, February 15-18, 2006:P363.
63. Wuillemin WA, Gasser KM, Zeerleder SS, et al. Evaluation of a platelet function analyser (PF-100) in patients with a bleeding tendency. Swiss Med Wkly 2002;132:443-8.